MMF and Calcineurin Taper in Recurrent Hepatitis C After Liver Transplantation: Impact on Histological Course

An algorithm for the grading of activity in chronic hepatitis C

1996 • 3,858 citations

Banff schema for grading liver allograft rejection: An international consensus document

1997 • 1,235 citations

Long-Term Outcome of Hepatitis C Infection after Liver Transplantation

1996 • 986 citations

Fundamental Immunology

1994 • 903 citations

HCV-related fibrosis progression following liver transplantation: increase in recent years

2000 • 750 citations

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

1996 • 669 citations

High Incidence of Allograft Cirrhosis in Hepatitis C Virus Genotype 1B Infection Following Transplantation: Relationship With Rejection Episodes

1999 • 547 citations

Recurrent and acquired hepatitis C viral infection in liver transplant recipients

1992 • 511 citations

Immunosuppressive strategies in transplantation

1999 • 461 citations

Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis C

2003 • 440 citations

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C

1999 • 363 citations

Mechanism of action of ribavirin in the combination treatment of chronic HCV infection

2002 • 349 citations

Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation

1996 • 313 citations

Early Identification of Recipients With Progressive Histologic Recurrence of Hepatitis C After Liver Transplantation

2000 • 200 citations

Liver Transplantation for Hepatitis C: Recurrence and Disease Progression in 300 Patients

2000 • 192 citations

New therapeutic strategies for hepatitis C

2002 • 156 citations

A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C

2002 • 140 citations

Banff schema for grading liver allograft rejection: Utility in clinical practice

1999 • 125 citations

Impact of immunosuppressive therapy on recurrence of hepatitis C

2002 • 124 citations

Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections

1996 • 110 citations

Mycophenolate Mofetil

1997 • 99 citations

MYCOPHENOLATEMOFETIL FOR IMMUNOSUPPRESSION AFTER LIVER TRANSPLANTATION

2003 • 90 citations

GRAFT LOSS FOLLOWING LIVER TRANSPLANTATION IN PATIENTS WITH CHRONIC HEPATITIS C1

1996 • 75 citations

Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro

1999 • 73 citations

PREVENTING ACUTE REJECTION, EPSTEIN-BARR VIRUS INFECTION, AND POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS AFTER KIDNEY TRANSPLANTATION: USE OF ACICLOVIR AND MYCOPHENOLATE MOFETIL IN A STEROID-FREE IMMUNOSUPPRESSIVE PROTOCOL1

1999 • 71 citations

Recent findings concerning liver transplantation in the United States.

1996 • 54 citations

Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells

2003 • 42 citations

The Immunobiology of Inductive Anti-CD40L Therapy in Transplantation: Allograft Acceptance is Not Dependent Upon the Deletion of Graft-Reactive T Cells

2002 • 41 citations

Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus

2000 • 35 citations

Consideration of mycophenolate mofetil for idiopathic pulmonary fibrosis

2001 • 16 citations

The anti-herpesvirus activity of (1′S,2′R)-9-[[1′,2′-bis(hydroxymethyl)cycloprop-1′-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil

2001 • 9 citations

Indications for mycofenolate mofetil therapy after liver transplantation

1997 • 8 citations